[EN] SUBSTITUTED PHENOXYMETHYL DIHYDRO OXAZOLOPYRIMIDINONES, PREPARATION AND USE THEREOF<br/>[FR] PHÉNOXYMÉTHYL-DIHYDRO-OXAZOLOPYRIMIDINONES SUBSTITUÉES, LEUR PRÉPARATION ET LEUR UTILISATION
申请人:SANOFI AVENTIS
公开号:WO2011034832A1
公开(公告)日:2011-03-24
The present invention relates to a series of substituted phenoxymethyl dihydro oxazolopyrimidinones of formula (I) defined herein. This invention also relates to methods of making these compounds including novel intermediates. The compounds of this invention are modulators of metabotropic glutamate receptors (mGluR), particularly, mGluR2 receptor. Therefore, the compounds of this invention are useful as pharmaceutical agents, especially in the treatment and/or prevention of a variety of central nervous system disorders (CNS), including but not limited to acute and chronic neurodegenerative conditions, psychoses, cognition deficit disorders, convulsions, anxiety, depression, migraine, pain, sleep disorders and emesis.
本发明涉及一系列被取代的苯氧甲基二氢噁唑吡咯嘧啶酮化合物,其化学式为(I)。本发明还涉及制备这些化合物的方法,包括新颖的中间体。本发明的化合物是代谢型谷氨酸受体(mGluR)的调节剂,特别是mGluR2受体。因此,本发明的化合物可用作药物制剂,特别是在治疗和/或预防各种中枢神经系统疾病(CNS)方面,包括但不限于急性和慢性神经退行性疾病、精神病、认知缺陷疾病、癫痫、焦虑、抑郁、偏头痛、疼痛、睡眠障碍和呕吐。